Comparison of Side Effects of COVID-19 Vaccines: Sinopharm, AstraZeneca, Sputnik V, and Covaxin in Women in Terms of Menstruation Disturbances, Hirsutism, and Metrorrhagia: A Descriptive-Analytical Cross-Sectional Study

Document Type : Original Article


1 Mazandaran University of Medical Sciences, Sari, Iran

2 Department of Infectious Diseases, Faculty of Medicin, Aja University of Medical Sciences, Tehran, Iran

3 Department of Pediatric Nursing, Faculty of Nursing, Aja University of Medical Sciences, Tehran, Iran

4 Department of Social Medicine, Faculty of Medicine, Aja University of Medical Sciences, Tehran, Iran

5 Department of critical Nursing, Faculty of Nursing, Aja University of Medical Sciences, Tehran, Iran

6 Department of Trauma, Faculty of Medicin, Aja University of Medical Sciences, Tehran, Iran


Background: Present study assessed whether Sinopharm, AstraZeneca, Sputnik V, and Covaxin’s vaccinated women
reveal a distinct incidence of menstruation disturbances, hirsutism, and metrorrhagia.
Materials and Methods: Data collection was performed from June to August 2021, and 427 women working in seven
selected hospitals in Tehran were studied in this descriptive-analytical cross-sectional study. All of these women had
received one or both doses of the vaccines with one of the assessed vaccines. Required data was collected via questionnaire and imported to SPSS 16 for further assessment and analysis. Fisher’s Exact Test and Chi-Squared test were
main statistical tests used to understand whether any significant relation exists or not.
Results: The participant’s mean age and body mass index (BMI) were 29.78 ± 10.55 and 23.27 ± 3.82, respectively.
Three hundred ninety-five cases (92.4%) had received both doses of the vaccines. Also, 154 cases (36.1%) had a history
of COVID-19. A total of 38 cases (8.8%) of menstruation disturbances, 20 cases (4.6%) of metrorrhagia, and 7
cases (1.6%) of hirsutism were reported after receiving the vaccines. There was a significant difference among the
vaccinated groups with the vaccines as mentioned earlier in terms of menstruation disturbances (hypermenorrhea,
dysmenorrhea, Amenorrhea) (P=0.01). The highest and the lowest incidence of menstruation disturbances were recorded
in the group vaccinated with Covaxin (17.6%) and Sputnik V (5%), respectively. There was also no significant
difference amongst the vaccinated groups with the four vaccines regarding the incidence of metrorrhagia and
hirsutism (P=0.10 and P=0.12, respectively). There was no significant relationship between all three complications
incidence with the previous infection concerning all vaccines (coefficient=0.46, 1.27, -0.15 respectively for menstruation
disturbances, metrorrhagia, and, hirsutism).
Conclusion: Seemingly, Covaxin revealed the most side effects in terms of menstruation disturbances. As a result, professionals must carry out several studies with reasonable samples to recommend the vaccine to those women confidently.


  1. Clapham HE, Cook AR. Face masks help control transmission of COVID-19. Lancet Digit Health. 2021; 3(3): e136-e137.
  2. Yadav AK. Impact of lockdown to control over Novel Coronavirus and COVID-19 in India. J Family Med Prim Care. 2020; 9(10): 5142-5147.
  3. Huang X, Shao X, Xing L, Hu Y, Sin DD, Zhang X. The impact of lockdown timing on COVID-19 transmission across US counties. EClinicalMedicine. 2021; 38: 101035.
  4. Saki M, Ghanbari MK, Behzadifar M, Imani-Nasab MH, Behzadifar M, Azari S, et al. The impact of the social distancing policy on COVID-19 incidence cases and deaths in iran from february 2020 to january 2021: Insights from an interrupted time series analysis. Yale J Biol Med. 2021; 94(1): 13-21.
  5. Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021; 21(10): 626-636.
  6. Yoshikawa T. Implementing vaccination policies based upon scientific evidence in Japan. Vaccine. 2021; 39(38): 5447-5450.
  7. Han X, Xu P, Ye Q. Analysis of COVID-19 vaccines: Types, thoughts, and application. J Clin Lab Anal. 2021; 35(9): e23937.
  8. Abu-Hammad O, Alduraidi H, Abu-Hammad S, Alnazzawi A, Babkair H, Abu-Hammad A, et al. Side effects reported by Jordanian healthcare workers who received COVID-19 vaccines. Vaccines (Basel). 2021; 9(6): 577.
  9. Jayadevan R, Shenoy RS, Anithadevi T. Survey of symptoms following COVID-19 vaccination in India. medRxiv. 2021.
  10. Stevenson WJ. An aspect of salk vaccination in adult women. Med J Aust. 1958; 2(10): 325-326.
  11. Hunter PR. Thrombosis after covid-19 vaccination. BMJ. 2021; 373: n958.
  12. Bell G, Montgomery D, Jarrett P. An unusual chronic cutaneous vaccine reaction; localised hypertrichosis, papular eczema and a subcutaneous nodule. Aust J Dermatol. 2016; 57(4): 324-326.
  13. Liu Y, Gold EB, Lasley BL, Johnson WO. Factors affecting menstrual cycle characteristics. Am J Epidemiol. 2004; 160(2): 131-140.
  14. Baker FC, Driver HS. Circadian rhythms, sleep, and the menstrual cycle. Sleep Med. 2007; 8(6): 613-622.
  15. Edozien LC. Mind over matter: psychological factors and the menstrual cycle. Curr Opin Obstet Gynecol. 2006; 18(4): 452-456.
  16. Xiao E, Ferin M. Stress-related disturbances of the menstrual cycle. Ann Med. 1997; 29(3): 215-219.
  17. Onieva-Zafra MD, Fernández-Martínez E, Abreu-Sánchez A, Iglesias-López MT, García-Padilla FM, Pedregal-González M, et al. Relationship between diet, menstrual pain and other menstrual characteristics among spanish students. Nutrients. 2020; 12(6): 1759.
  18. Reavey JJ, Walker C, Murray AA, Brito-Mutunayagam S, Sweeney S, Nicol M, et al. Obesity is associated with heavy menstruation that may be due to delayed endometrial repair.J Endocrinol. 2021; 249(2): 71-82.
  19. Weinberg CR. The influence of occupational activity on the menstrual cycle and fecundability. Epidemiology. 1994; 5(1): 14-18.
  20. Batista MC, Cartledge TP, Zellmer AW, Merino MJ, Axiotis C, Bremner WJ, et al. Effects of aging on menstrual cycle hormones and endometrial maturation. Fertil Steril. 1995; 64(3): 492-499.
  21. Braithwaite D, Moore DH, Lustig RH, Epel ES, Ong KK, Rehkopf DH, et al. Socioeconomic status in relation to early menarche among black and white girls. Cancer Causes Control. 2009; 20(5): 713-720.
  22. James-Todd T, Tehranifar P, Rich-Edwards J, Titievsky L, Terry MB. The impact of socioeconomic status across early life on age at menarche among a racially diverse population of girls. Ann Epidemiol. 2010; 20(11): 836-842.
  23. Tehranifar P, Reynolds D, Flom J, Fulton L, Liao Y, Kudadjie-Gyamfi E, et al. Reproductive and menstrual factors and mammographic density in African American, Caribbean, and white women. Cancer Causes Control. 2011; 22(4): 599-610.
  24. Garcia C, Lee PC, Rosetta L. Impact of social environment on variation in menstrual cycle length in captive female olive baboons (Papio anubis). Reproduction. 2008; 135(1): 89-97.
  25. Tavakol M, Dennick R. Making sense of Cronbach's alpha. Int J Med Educ. 2011; 2: 53-55.
  26. Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, et al. Thrombocytopenia following Pfizer and Moderna SARSCoV- 2 vaccination. Am J Hematol. 2021; 96(5): 534-537.
  27. Rajpurkar M, O'Brien SH, Haamid FW, Cooper DL, Gunawardena S, Chitlur M. Heavy menstrual bleeding as a common presenting symptom of rare platelet disorders: illustrative case examples. J Pediatr Adolesc Gynecol. 2016; 29(6): 537-541.
  28. Díaz-Quijano FA, Villar-Centeno LA, Martínez-Vega RA. Complications associated to severe thrombocytopenia in patients with dengue. Rev Med Chil. 2006; 134(2): 167-173.
  29. Perricone C, Ceccarelli F, Nesher G, Borella E, Odeh Q, Conti F, et al. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol Res. 2014; 60(2-3): 226-235.
  30. Mathioudakis AG, Ghrew M, Ustianowski A, Ahmad S, Borrow R, Papavasileiou LP, et al. Self-reported real-world safety and reactogenicity of covid-19 vaccines: a vaccine recipient survey. Life (Basel). 2021; 11(3): 249.
  31. Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020; 382(17): e38.
  32. Acanfora D, Acanfora C, Ciccone MM, Scicchitano P, Bortone AS, Uguccioni M, et al. The cross-talk between thrombosis and inflammatory storm in acute and long-COVID-19: therapeutic targets and clinical cases. Viruses. 2021; 13(10): 1904.
  33. Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 54-65.
  34. Wang X, Cheng Z. Cross-sectional studies: strengths, weaknesses, and recommendations. Chest. 2020; 158(1S): S65-S71.
  35. Silles MA. The causal effect of education on health: evidence from the United Kingdom. Econ Educ Rev. 2009; 28(1): 122-128.
  36. Simonds SK. Health education as social policy. Health Educ. 1974; 2(1_suppl): 1-10.
  37. McHugh MC. Menstrual Shame: Exploring the role of 'menstrual moaning'. In: Bobel C, Winkler IT, Fahs B, Hasson KA, Kissling EA, Roberts TA, editors. The palgrave handbook of critical menstruation studies. Singapore: Palgrave Macmillan. 2020; 32: 409-422.
  38. Hernández AF, Calina D, Poulas K, Docea AO, Tsatsakis AM. Safety of COVID-19 vaccines administered in the EU: Should we be concerned? Toxicol Rep. 2021; 8: 871-879.
  39. Bentov Y, Beharier O, Moav-Zafrir A, Kabessa M, Godin M, Greenfield CS, et al. Ovarian follicular function is not altered by SARS-Cov-2 infection or BNT162b2 mRNA Covid-19 vaccination. Hum Reprod. 2021; 36(9): 2506-2513.
  40. Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N, et al. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel. N Engl J Med. 2021; 385(15): 1393-1400.